Lazard Asset Management’s DocGo DCGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,713
Closed -$7K 2357
2024
Q4
$7K Sell
1,713
-239,355
-99% -$922K ﹤0.01% 2113
2024
Q3
$800K Buy
241,068
+101,389
+73% +$345K ﹤0.01% 1187
2024
Q2
$431K Buy
139,679
+85,400
+157% +$281K ﹤0.01% 1258
2024
Q1
$219K Buy
54,279
+29,964
+123% +$113K ﹤0.01% 1262
2023
Q4
$135K Buy
+24,315
New +$140K ﹤0.01% 1537
2023
Q1
Sell
-9,073
Closed -$64K 2346
2022
Q4
$64K Buy
+9,073
New +$76.1K ﹤0.01% 1694
2022
Q3
Sell
-18,690
Closed -$133K 2366
2022
Q2
$133K Buy
18,690
+7,891
+73% +$57.5K ﹤0.01% 1397
2022
Q1
$99K Buy
10,799
+5,381
+99% +$40.5K ﹤0.01% 1403
2021
Q4
$50K Buy
+5,418
New +$50.3K ﹤0.01% 1739

Other funds holding DCGO

Lazard Asset Management's DCGO Position: Q1 2025 in Review

Lazard Asset Management sold out of DocGo (DCGO) in Q1 2025, closing a stake of 1,713 shares — an estimated $7K sold.

Lazard Asset Management first reported a position in DCGO in Q4 2021 and held it in 9 quarters. The position peaked at $800K in Q3 2024. 135 funds tracked by Wall St. Rank hold DCGO as of Q1 2025.

  • Lazard Asset Management reported no remaining DocGo position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 1,713 DocGo shares in Q1 2025, an estimated $7K.
  • Lazard Asset Management first reported a position in DocGo in Q4 2021 and held it in 9 quarters.
  • Lazard Asset Management's DocGo position peaked at $800K in Q3 2024.
  • 135 funds tracked by Wall St. Rank held DocGo as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.